Status:
COMPLETED
Single Ascending Dose Study (SAD) iv Formulation
Lead Sponsor:
AstraZeneca
Conditions:
Healthy
Eligibility:
MALE
20-45 years
Phase:
PHASE1
Brief Summary
The purpose is to study the safety of AZD1305, how AZD1305 is tolerated and how the medication is metabolised by the body (how it is taken up into the body, distributed around the body and disappears ...
Eligibility Criteria
Inclusion
- Healthy volunteers
- BIM 19-30 kg/m2
Exclusion
- Potassium outside normal reference values
- ECG findings outside normal range
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2008
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00688831
Start Date
January 1 2008
End Date
May 1 2008
Last Update
December 2 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Uppsala, Sweden